美股AI医药开发概念股盘后上涨，美国FDA放弃动物试验原则
Certara, Inc.（CERT）美股盘后涨24%， Schrodinger Inc. （SDGR）涨16%， Recursion Pharmaceuticals, Inc. （RXRX）涨20%， Absci Corporation. （ABSI）涨12%， 查尔斯河 （CRL）涨超4%。
消息面上，美国食品药品管理局（FDA）宣称，将在单抗等诸多药物方面逐步放弃动物试验路线，转而追求“更有效的人类相关研究方法”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10